Inhibition of FUT3 and FUT6 has been shown to affect TGF-β receptor glycosylation, resulting in decreased fucosylation as well as FUT3/6-associated sialyl Lewis antigens and altered TGF-β-mediated EMT and invasion in colorectal cancer cells [69]. This evidence concerns the gene TGFB1 and colorectal cancer.